Hjem › Major depresjon › Georgia
Kliniske studier for Major depresjon i Georgia
33 studier for Major depresjon søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
- AGILE Clinical Research Trials, LLC, Sandy Springs
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Agile Clinical Research Trials, LLC, Atlanta
- Accelerated Clinical Research Group LLC, Snellville
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07573176Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- Emory Healthcare, Atlanta
Rekrutterer
Alder 22 til 85 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07594483JAK Signaling in Depression
- Emory University, Atlanta
RekruttererFase 2
Alder 25 til 55 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07003997Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Advanced Discovery Research, Atlanta
- Agile Clinical Research Trials, LLC, Atlanta
- iResearch Atlanta LLC, Decatur
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Evergreen Clinical Trials, Norcross
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- The Emory Clinic, Atlanta
- CenExeli Research LLC, Decatur
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05850689A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Peachford Hospital-Atlanta Behavioral Research, Atlanta
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Psych Atlanta, Marietta
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07105111A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Atlanta
- Seaport Investigator Site, Decatur
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07065240Leucine in Midlife Depression
- Emory University Hospital, Atlanta
RekruttererFase 2
Alder 35 til 65 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06580145A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Delricht Research, Atlanta
- Emory University Brain Health Center, Atlanta
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Decatur
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Emory University Hospital, Atlanta
Rekrutterer
Alder 22 til 70 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Atlanta
- Draig Clinical Site, Decatur
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- CenExel - Atlanta Center for Medical Research, Atlanta
- CenExel - iResearch Atlanta, Decatur
- CenExel - iResearch Savannah, Savannah
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Advanced Discovery Research, Atlanta
- Synexus - Atlanta, Atlanta
- Psych Atlanta, Pc, Marietta
- og 1 flere
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- CenExel iRS (iResearch Savannah), Savannah
RekruttererFase 2
Alder 18 til 64 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Denali Health Atlanta, LLC, Stone Mountain
RekruttererFase 2
Alder 18 til 64 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Atlanta
- Clinical Research Site, Norcross
- Clinical Research Site, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. jul. 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Trialmed /ID# 277601, Atlanta
- Evergreen Clinical Trials - Norcross /ID# 279421, Norcross
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07276997Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
- Emory University, Atlanta
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 26. mai 2026 · NCT05327699A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExcel, Decatur
- CenExel, Savannah
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06524830REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Savannah VA Clinic, Savannah
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 29. apr. 2026 · NCT07280065Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
RekruttererObservasjonsstudie
Alder 18 til 40 · Alle kjønn · Oppdatert 10. mar. 2026 · NCT06740383Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #112, Decatur
- Autobahn Site #142, Peachtree Corners
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 20. jan. 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 224, Savannah
- Site 208, Snellville
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 24. jul. 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Atlanta
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 23. jan. 2025 · NCT06223880Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.